; Throat Cancer - Pipeline Review, H2 2011
Documents
Resources
Learning Center
Upload
Plans & pricing Sign in
Sign Out
Your Federal Quarterly Tax Payments are due April 15th Get Help Now >>

Throat Cancer - Pipeline Review, H2 2011

VIEWS: 1 PAGES: 35

Throat Cancer - Pipeline Review, H2 2011 Summary Global Markets Direct’s, 'Throat Cancer - Pipeline Review, H2 2011', provides an overview of the Throat Cancer therapeutic pipeline. This report provides information on the therapeutic development for Throat Cancer, complete with latest updates, and special features on late-stage and discontinued projects. It also reviews key players involved in the therapeutic development for Throat Cancer. 'Throat Cancer - Pipeline Review, H2 2011' is built using data and information sourced from Global Markets Direct’s proprietary databases, Company/University websites, SEC filings, investor presentations and featured press releases from company/university sites and industry-specific third party sources, put together by Global Markets Direct’s team. Note*: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease. Scope - A snapshot of the global therapeutic scenario for Throat Cancer. - A review of the Throat Cancer products under development by companies and universities/research institutes based on information derived from company and industry-specific sources. - Coverage of products based on various stages of development ranging from discovery till registration stages. - A feature on pipeline projects on the basis of monotherapy and combined therapeutics. - Coverage of the Throat Cancer pipeline on the basis of route of administration and molecule type. - Profiles of late-stage pipeline products featuring sections on product description, mechanism of action and research & development progress. - Key discontinued pipeline projects. - Latest news and deals relating to the products. Reasons to buy - Identify and understand important and diverse types of therapeutics under development for Throat Cancer. - Identify emerging players with potentially strong product portfolio and design effective counter-strategies to gain competitive

More Info
  • pg 1
									Throat Cancer – Pipeline Review, H2 2011




                      Throat Cancer - Pipeline Review, H2 2011
                                                                                          Reference Code: GMDHC1210IDB

                                                                                          Publication Date: August 2011




Throat Cancer – Pipeline Review, H2 2011                                                                          GMDHC1210IDB / Pub August 2011
© Global Markets Direct. This report is a licensed product and is not to be photocopied
                                                                                                                                         Page(1)
Throat Cancer – Pipeline Review, H2 2011



Ta b le o f Co n te n ts
Table of Contents                                                                                                  2
List of Tables                                                                                                     3
List of Figures                                                                                                    4
Introduction                                                                                                       5
     Global Markets Direct Report Coverage                                                                         5
Throat Cancer Overview                                                                                             6
Therapeutics Development                                                                                           7
     An Overview of Pipeline Products for Throat Cancer                                                            7
Throat Cancer Therapeutics under Investigation by Universities/Institutes                                          9
Mid Clinical Stage Products                                                                                       11
     Comparative Analysis                                                                                         11
Early Clinical Stage Products                                                                                     12
     Comparative Analysis                                                                                         12
Throat Cancer Therapeutics - Products under Investigation by Universities/Institutes                              13
Throat Cancer - Therapeutics Assessment                                                                           14
     Assessment by Monotherapy Products                                                                           14
     Assessment by Combination Products                                                                           15
     Assessment by Route of Administration                                                                        16
     Assessment by Molecule Type                                                                                  18
Drug Profiles                                                                                                     20
     Capecitabine - Drug Profile                                                                                  20
          Product Description                                                                                     20
          Mechanism of Action                                                                                     20
          R&D Progress                                                                                            20
     Tarceva + Celebrex + Radiation Therapy - Drug Profile                                                        21
          Product Description                                                                                     21
          Mechanism of Action                                                                                     21
          R&D Progress                                                                                            21
     Cetuximab - Drug Profile                                                                                     22
          Product Description                                                                                     22
          Mechanism of Action                                                                                     22
          R&D Progress                                                                                            22
     Bevacizumab + Cisplatin + Fluorouracil + Radiation Therapy - Drug Profile                                    24
          Product Description                                                                                     24
          Mechanism of Action                                                                                     24
          R&D Progress                                                                                            24
     docetaxel + cisplatin + fluorouracil - Drug Profile                                                          26
          Product Description                                                                                     26
          Mechanism of Action                                                                                     26
          R&D Progress                                                                                            26
     Ad5CMV-p53 Gene + Cisplatin + Radiation Therapy - Drug Profile                                               28
          Product Description                                                                                     28
          Mechanism of Action                                                                                     28
          R&D Progress                                                                                            28
     Cytochlor + Tetrahydrouridine + Radiation Therapy - Drug Profile                                             30
          Product Description                                                                                     30
          Mechanism of Action                                                                                     30


Throat Cancer – Pipeline Review, H2 2011                                                  GMDHC1210IDB / Pub August 2011
© Global Markets Direct. This report is a licensed product and is not to be photocopied                           Page(2)
Throat Cancer – Pipeline Review, H2 2011


          R&D Progress                                                                                            30
     Bevacizumab + Cisplatin + Fluorouracil - Drug Profile                                                        32
          Product Description                                                                                     32
          Mechanism of Action                                                                                     32
          R&D Progress                                                                                            32
Appendix                                                                                                          34
     Methodology                                                                                                  34
          Coverage                                                                                                34
          Secondary Research                                                                                      34
          Primary Research                                                                                        34
          Expert Panel Validation                                                                                 35
     Contact Us                                                                                                   35
     Disclaimer                                                                                                   35




Lis t o f Ta b le s
Number of Products Under Development for Throat Cancer, H2 2011                                                    7

Products under Development for Throat Cancer – Comparative Analysis, H2 2011                                       8

Number of Products under Investigation by Universities/Institutes, H2 2011                                        10

Comparative Analysis by Mid Clinical Stage Development, H2 2011                                                   11

Comparative Analysis by Early Clinical Stage Development, H2 2011                                                 12

Products under Investigation by Universities/Institutes, H2 2011                                                  13

Assessment by Monotherapy Products, H2 2011                                                                       14

Assessment by Combination Products                                                                                15

Assessment by Stage and Route of Administration, H2 2011                                                          17

Assessment by Molecule Type, H2 2011                                                                              19




Throat Cancer – Pipeline Review, H2 2011                                                  GMDHC1210IDB / Pub August 2011
© Global Markets Direct. This report is a licensed product and is not to be photocopied                           Page(3)
Throat Cancer – Pipeline Review, H2 2011




Lis t o f Fig u re s
Number of Products under Development for Throat Cancer, H2 2011 .....
								
To top